510(k) Report

FDA applicant

Shanghai Genext Medical Technology Co., Ltd.

Shanghai, CN1 decision2023–20230 recalls

FDA records 1 decision for Shanghai Genext Medical Technology Co., Ltd. (Shanghai, CN) in 2023: 1 510(k) clearance. All are in product code MLM (Enzyme Immunoassay, Tracrolimus). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Shanghai Genext Medical Technology Co., Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2023: 1
2023high 1 (2023) · low 0 (2024)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2023.

FIG. 1 — Shanghai Genext Medical Technology Co., Ltd. by year, 2023–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Shanghai Genext Medical Technology…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • MLMEnzyme Immunoassay, Tracrolimus1decision

Whose devices does it build on?

Its devices cite 1 predicate; 0 are its own earlier devices. The firms it cites most:

What has FDA decided for it lately?

  • K203833Tacrolimus Assay KitShanghai Genext Medical Technology Co., Ltd. · 2023

The one decision as Shanghai Genext Medical Technology Co., Ltd. →